Kraig Biocraft Laboratories, Inc. KBLB
$0.08
$0.00-1.35%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.04% | -54.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.22% | -49.60% | |||
| Operating Income | -14.22% | 49.60% | |||
| Income Before Tax | -19.69% | 47.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.69% | 47.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.69% | 47.83% | |||
| EBIT | -14.22% | 49.60% | |||
| EBITDA | -14.57% | 49.92% | |||
| EPS Basic | -28.57% | 50.00% | |||
| Normalized Basic EPS | -20.00% | 44.44% | |||
| EPS Diluted | -28.57% | 50.00% | |||
| Normalized Diluted EPS | -20.00% | 44.44% | |||
| Average Basic Shares Outstanding | 0.96% | 1.14% | |||
| Average Diluted Shares Outstanding | 0.96% | 1.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||